- Report
- November 2023
- 139 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- November 2023
- 148 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- October 2023
- 229 Pages
Global
From €5285EUR$5,499USD£4,532GBP
- Report
- September 2023
- 139 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- May 2023
- 143 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- May 2024
- 93 Pages
Global
From €5382EUR$5,600USD£4,616GBP
- Report
- March 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- March 2024
- 141 Pages
Global
From €3748EUR$3,899USD£3,214GBP
- Report
- January 2024
- 182 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- November 2023
- 245 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- November 2023
- 420 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- February 2024
- 115 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- March 2024
- 134 Pages
Global
From €7641EUR$7,950USD£6,553GBP
- Report
- March 2024
- 30 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- January 2024
- 120 Pages
Global
From €7641EUR$7,950USD£6,553GBP
- Report
- January 2024
- 158 Pages
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- August 2023
- 118 Pages
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- November 2023
- 174 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- November 2023
- 190 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- November 2023
- 178 Pages
Global
From €4710EUR$4,900USD£4,039GBP
The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more